Please login to the form below

autoimmune disease

This page shows the latest autoimmune disease news and features for those working in and with pharma, biotech and healthcare.

GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis

The rare autoimmune disease affects two to ten people per million and has limited treatments. ... Affecting two to ten people per million, SSc is a rare autoimmune disease that causes unusual growth of connective tissues and can affect a patient’s

Latest news

Gilead and EVOQ Therapeutics partner in deal potentially worth over $650m

According to the National Institutes of Health, up to 23.5 million people are living with an autoimmune disease in the US alone, and the prevalence is rising. ... EVOQ also partnered with Amgen in January 2021 to discover and develop novel drugs for
Takeda to acquire Nimbus’ TYK2 inhibitor in deal worth $6bn

the differentiation of this molecule within the TYK2 class, and we believe in its broad potential for people with autoimmune diseases. ... Earlier this month, Takeda’s dengue vaccine candidate, Qdenga (TAK-003), was approved by the European Commission
AbbVie receives extended SMC recommendation for Rinvoq in rheumatoid arthritis patients

In Scotland, there are around 44, 000 people living with the progressive autoimmune disease. ... A progressive autoimmune disease, RA sees the immune system attacking the lining of the joints, which leads to inflammation and symptoms such as pain,
Amgen announces plans to acquire Horizon for $27.8bn in biggest pharma deal for 2022

criteria’. Amgen will benefit from gaining several approved therapies as part of the deal, with Horizon’s pipeline of rare autoimmune and inflammatory disease drugs bolstering Amgen’s offering. ... Included in this is Horzion’s Tepezza, a
BioNTech and Ryvu partner to develop immuno-modulatory small molecule candidates

The focus will be on immune modulation within oncology and potentially other disease areas. ... combinations. The STING pathway plays a critical role during infections and autoimmune disease, as well as one of the key innate immunity pathways responsible

More from news
Approximately 13 fully matching, plus 98 partially matching documents found.

Latest Intelligence

Building a brighter future with patient support programmes

Valuing patient data. VISFO, which has health economists, medics, data scientists, immunologists and software engineers on its teams, is creating its own PSP, free from industry investment, for the autoimmune disease ... HCPs, through longitudinal
Should we stop talking about people as patients and start thinking of them as partners? After all, it is their physical and mental health and well-being

You may ask why we looked at lupus? Because there is a massive unmet need with this autoimmune disease. ... To find support for, and be able to support others through, the heavy mental and emotional burden of this chronic debilitating disease.
A new era for UK-Japanese scientific research relations

Japan’s health system is seeing a corresponding rise in the conditions common to an ageing population, such as cardiac disease, autoimmune diseases, diabetes, osteoporosis and osteoarthritis.
30 Women Leaders in UK Healthcare (part 2)

ecosystem. In her 25-plus years in the sector, her investments have resulted in the launch of six drugs, spanning inflammatory and autoimmune disease and cancer.
Managing medication non-adherence

Autoimmune conditions such as Crohn’s disease can flare up through an imbalance of things like stress, lack of sleep or overworking - not just as a direct consequence of nonadherence to

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

New hires at Nanoform, Leo Pharma and Calliditas

IgA nephropathy (IgAN) – also known as Berger’s disease. ... Currently, there are no approved treatments for IgA Nephropathy, and Nefecon has the potential to be a disease-modifying treatment for patients suffering from this chronic autoimmune disease
Akari Therapeutics strengthens board

His expertise has seen him led transactions across a broad span of deal-types, geographies, and therapeutic disease areas and he brings experience in business and corporate development, finance, marketing and ... As Akari continues its mission to develop
David Horn Solomon takes the helm of Akari Therapeutics

biopharma as it focuses on the development and commercialisation of orphan autoimmune and inflammatory disease treatments.
Caldan Therapeutics appoints CEO

Dr Payton joins the metabolic disease specialist - a spin-out company from the Universities of Glasgow and Southern Denmark - from MAPBiotech, where he has served as chief executive officer since 2014. ... He co-founded autoimmune disease-focused Orca
Santhera CEO Klaus Schollmeier joins SuppreMol

In his new position at autoimmune disease specialists SuppreMol, Schollmeier succeeds Professor Peter Buckell who retires. ... He said: "The company has a very promising product candidate for the treatment of autoimmune diseases in phase II clinical

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

What does the future hold for clinical trial recruitment?

For example, new commonalities have been discovered between Type 1 diabetes, lupus, multiple sclerosis and rheumatoid arthritis, suggesting that drugs already in use to treat one autoimmune disease could be equally
RP Investigates - Q&A session: Living with Lupus

This session is a perfect opportunity to listen first-hand to a patient suffering with this debilitating autoimmune disease and find out how pharma can help.
Lupus Awareness Month

Lupus is an autoimmune disease as it causes the immune system to attack healthy cells in the body.
The other side of … Crohn’s disease

The other side of … Crohn’s disease. “After visiting about seven doctors in two different countries, I am confident to say that all can align on 2–3 points at most”. ... Meet Irene. Like millions of others worldwide (and an estimated 115, 000
PANDAS/PANS Awareness: A parent’s story

parent of a son recently diagnosed with PANDAS (paediatric autoimmune neuropsychiatric disorder associated with Streptococcus)…. ... As PANDAS is an autoimmune disease that leads to inflammation in the basal ganglia region of the brain, the symptoms

More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...: Highly competitive salary

Principal Medical Writer, Facial Aesthetics, Medical Communicati...: 65-75K

Exciting Medical Writer Career Opportunity for Postdoc, Medcomms: Highly competitive salary

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Lead Market Access Writer, £5K joining bonus, UK: Highly competitive salary

PMHub

Add my company

Springer Nature

Operating in 50+ countries, we’re a leading research, educational, and professional publisher dedicated to advancing scientific discovery. Whether you’re looking...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines: Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour: Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age: In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...

Email:
Password:

Please login to the form below

autoimmune disease

Subscribe to our email news alerts

Featured jobs

Quick links